Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
A compounded oral rinse containing diphenhydramine (an antihistamine with local anesthetic properties), lidocaine (a local anesthetic), and antacids (commonly aluminum hydroxide and magnesium hydroxide, as found in Maalox or Mylanta). This combination is most commonly known as "magic mouthwash" and is used to provide symptomatic relief from oral mucositis pain, particularly in patients undergoing cancer therapy such as radiotherapy for head and neck cancers. Diphenhydramine reduces swelling and provides mild anesthesia; lidocaine numbs the mucosa to relieve pain; antacids help coat the sores for additional protection. The formulation is typically prepared by compounding pharmacies according to a physician’s prescription[1][2][4][6][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on diphenhydramine + lidocaine + antacids.